Orchestra BioMed Holdings Inc.
Organization details
- Legal name
- Orchestra BioMed Holdings Inc.
- Former names
- Health Sciences Acquisitions Corp 2
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New Hope
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001814114
Board of directors
-
Chris Cleary · DirectorSince 2025
-
Connealy Pamela Yanchik · DirectorSince 2023
-
Darren Sherman · Director · See RemarksSince 2023
-
David P. Hochman · Director · See RemarksSince 2023
-
David Pacitti · DirectorSince 2024
-
Eric A. Rose M.D. · DirectorSince 2023
-
Eric S. Fain · DirectorSince 2023
-
Geoffrey Wade Smith · DirectorSince 2023
-
Jason Aryeh · DirectorSince 2023
-
John Prosper Mack · DirectorSince 2024
-
Roderick Wong · Director · Chief Executive OfficerSince 2023
-
Yuval Mika · Director · See RemarksSince 2023
Chief executives
Director election results
Annual meeting of June 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.0%
-
99.3%
-
99.8%
Board connections
2 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Lifecore Biomedical Inc. Same sectorvia Jason Aryeh
-
Ligand Pharmaceuticals Incorporated Same sectorvia Jason Aryeh
-
Rocket Pharmaceuticals Inc. Same sectorvia Roderick Wong
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $6,489,541
- 13 purchases by 7 insiders
- Sold, last 12 months
- $439,182
- 7 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 9, 2026 | Eric S. Fain Director | Open-market purchase | +20,000 | $5.00 | $100,000 |
| Nov 9, 2026 | David P. Hochman Director, Officer (See Remarks) | Open-market purchase | +5,000 | $5.00 | $25,000 |
| Nov 9, 2026 | Taylor Andrew Lawrence Officer (Chief Financial Officer) | Open-market purchase | +1,000 | $5.00 | $5,000 |
| Nov 9, 2026 | David Pacitti Director | Open-market purchase | +20,000 | $5.00 | $100,000 |
| Nov 9, 2026 | RTW INVESTMENTS, LP 10% owner | Open-market purchase | +1,200,000 | $5.00 | $6,000,000 |
| Nov 2, 2026 | Darren Sherman Director, Officer (See Remarks) | Open-market sale | −15,000 | $5.74 | $86,100 |
| Oct 1, 2026 | Darren Sherman Director, Officer (See Remarks) | Open-market sale | −15,000 | $6.36 | $95,400 |
| Sep 10, 2026 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −3,283 | $5.81 | $19,074 |
| Sep 10, 2026 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −3,283 | $5.81 | $19,074 |
| Sep 3, 2026 | David P. Hochman Director, Officer (See Remarks) | Open-market purchase | +10,000 | $4.79 | $47,900 |
| Sep 1, 2026 | Darren Sherman Director, Officer (See Remarks) | Open-market sale | −15,000 | $4.94 | $74,100 |
| Aug 26, 2026 | Aiello Joshua Officer (Principal Accounting Officer) | Shares withheld for tax | −203 | $5.26 | $1,068 |
| Aug 26, 2026 | Darren Sherman Director, Officer (See Remarks) | Shares withheld for tax | −4,925 | $5.26 | $25,906 |
| Aug 26, 2026 | Taylor Andrew Lawrence Officer (Chief Financial Officer) | Shares withheld for tax | −3,076 | $5.26 | $16,180 |
| Aug 26, 2026 | Darren Sherman Director, Officer (See Remarks) | Open-market purchase | +2,000 | $5.33 | $10,660 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Orchestra BioMed Holdings Inc.
Who is the CEO of Orchestra BioMed Holdings Inc.?
Roderick Wong is Orchestra BioMed Holdings Inc.'s Chief Executive Officer.
How many directors are on Orchestra BioMed Holdings Inc.'s board?
Orchestra BioMed Holdings Inc.'s board has 12 directors: Chris Cleary, Connealy Pamela Yanchik, Darren Sherman, David P. Hochman, David Pacitti, Eric A. Rose M.D., Eric S. Fain, Geoffrey Wade Smith, Jason Aryeh, John Prosper Mack and 2 others.
Are Orchestra BioMed Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Orchestra BioMed Holdings Inc. insiders bought $6.5 million of shares in 13 purchases and sold $439,182 of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="orchestra-biomed-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.